AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2016
Nov 18, 2016
29755_dirs_2016-11-18_10e88ec3-11ce-4da5-9e7b-f864c3549e33.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2016-11-16
Reporting Person: HURWICH THOMAS A. (VP, Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-16 | Common stock, $0.01 par value | M | 3100 | $28.8628 | Acquired | 64549 | Direct |
| 2016-11-16 | Common stock, $0.01 par value | S | 3100 | $62.00 | Disposed | 61449 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-16 | Option (right to buy) | $28.8628 | A | 3100 | Disposed | 2018-02-14 | Common stock (3100) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.01 par value | 442 | Indirect |
| Common stock, $0.01 par value | 274 | Indirect |
Footnotes
F1: Balance in the AbbVie Savings Program as of November 16, 2016.
F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4